Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.

Human reproduction (Oxford, England) - 1 Mar 2001

Hundscheid R D, Braat D D, Kiemeney L A, Smits A P, Thomas C M

Abstract excerpt

Fragile X premutations are known to be a risk factor for diminished ovarian function at a relatively young age. We studied endocrine profiles of female fragile X family members (n = 79) at risk of premature ovarian failure (POF). Of these 79 women aged <40 years, 45 had menstrual cycles, and 34 were using oral contraceptives. Of the women with menstrual cycles, the premutation carriers had higher serum FSH...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Contraceptives, Oral
Share to Follicle Stimulating Hormone

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Fragile X Syndrome

Share to Heterozygote

Share to Menstrual Cycle

Share to Mutation

Share to Osmolar Concentration

Share to Primary Ovarian Insufficiency

Source

Identifiers

PMID: 11228211
DOI: 10.1093/humrep/16.3.457

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives.PMID 11228211Read ↗

Evidence of early ovarian aging in fragile X premutation carriers.Semantic proximity Read ↗

Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women.Semantic proximity Read ↗

Premature ovarian failure: a phenotypic expression of fragile X premutation.Semantic proximity Read ↗

Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry.Semantic proximity Read ↗

Reproductive and menstrual history of females with fragile X expansions.Semantic proximity Read ↗

Fragile X premutation in women with sporadic premature ovarian failure in Slovenia.Semantic proximity Read ↗

Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.Semantic proximity Read ↗

Ovarian reserve in patients with FMR1 gene premutation and the role of fertility preservation.Semantic proximity Read ↗

Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure.Semantic proximity Read ↗

Female fragile X premutation carriers are at increased risk for metabolic syndrome from early adulthood.Semantic proximity Read ↗

X chromosome inactivation does not define the development of premature ovarian failure in fragile X premutation carriers.Semantic proximity Read ↗

Genetic evidence that lower circulating FSH levels lengthen menstrual cycle, increase age at menopause and impact female reproductive health.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.